predictions, page-61

gvodzen

a couple of points:

1. No information has been released on the profitability of the imaging business. I would guess that it is operating on an EBITDA margin of 10 - 15%, so maybe $1 million of EBITDA if we are lucky.

2. We don't know anything about the revenue model for the Asian intelliheart machines except that IMI will be charging a fee per patient as well as for the machines upfront. However, I would urge caution regarding a) the number of times each machine is used each day. Until proven otherwise, I would assume three patients a day, b) the amount of revenue per test to be received by IMI. Given that the machines are being sold, I would be very suprised if rev to IMI per test was more than $50 and could be a lot lower.

Cheers

Red